Barclays believes that Nike management is doing a good job in righting the ship. The bank upgraded the athleisure stock to an ...

Nike Inc. (NYSE:NKE) shares rose 2% Wednesday after Barclays upgraded the athletic apparel company to Overweight from Equalweight and raised its price target to $73 from $64.

Nike Inc. (NYSE:NKE) rose about 2% on Wednesday after Barclays upgraded the sportswear giant to Overweight from Equalweight and lifted its price target to $73 from $64. Barclays analyst Adrienne Yih ...

Full Year 2025 Sales Increased to $59.1 Million, Up 2.3%, Compared to $57.8 Million for the Full Year of 2024. Net sales for the year ended December 31, 2025, were $59.1 million, ...

West Pharmaceutical Services, Inc. WST is well-positioned for growth, backed by strong demand for HVPs, expanding GLP-1 drug programs and regulatory-driven Annex 1 conversions. However, tariff impacts ...

We finished fiscal 2025 surpassing our expectations on both the top line and bottom line for the fourth quarter relative to our outlook provided in early December. We ended the fiscal year with six ...

Verrica Pharmaceuticals (NASDAQ:VRCA) used its fourth quarter and year-end 2025 corporate update call to highlight what management described as a “fundamental” business transformation driven by ...

In most organizations, by the time a signal reaches the next planning cycle, it’s been delayed, aggregated or lost entirely.

India’s ABS leader posts 29.5% ROE, remains debt-free, but Thailand acquisition bleeds Rs 28 crore a quarter amid Rs 350 crore expansion and rising FY28 competition ...